NRD
USNA icon

Nebula Research & Development’s Usana Health Sciences USNA Stock Holding History

Nebula Research & Development’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,069
Closed -$245K – 1165
2025
Q1 		$245K Buy
+9,069
New +$287K 0.02% 814
2024
Q2 		– Sell
-9,658
Closed -$468K – 1061
2024
Q1 		$468K Sell
9,658
-453
-4% -$22.2K 0.1% 374
2023
Q4 		$542K Buy
+10,111
New +$511K 0.16% 228

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nebula Research & Development's USNA Position: Q2 2025 in Review

Nebula Research & Development sold out of Usana Health Sciences (USNA) in Q2 2025, closing a stake of 9,069 shares — an estimated $245K sold.

Nebula Research & Development first reported a position in USNA in Q4 2023 and held it in 3 quarters. The position peaked at $542K in Q4 2023. 164 funds tracked by Wall St. Rank hold USNA as of Q2 2025.

  • Nebula Research & Development reported no remaining Usana Health Sciences position as of Q2 2025 after selling out during the quarter.
  • Nebula Research & Development sold 9,069 Usana Health Sciences shares in Q2 2025, an estimated $245K.
  • Nebula Research & Development first reported a position in Usana Health Sciences in Q4 2023 and held it in 3 quarters.
  • Nebula Research & Development's Usana Health Sciences position peaked at $542K in Q4 2023.
  • 164 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2025.

Based on Nebula Research & Development's 13F filing for Q2 2025, filed 14 Aug 2025.